Update me

If you would appreciate to receive an email when there is a significant update on the drugs associated with Brugada syndrome (e.g. drugs added, removed or with changed qualifications), please fill in this form.

When you would like us to stop sending you email updates, please click here

Most importantly, this mailing list includes updates of the patient letter, the letter which harbours all drugs on this site and can be given to patients and all of their health care provides (including specialists, general practitioners, dentists and pharmacists).

History of drug updates

  • 2011, July, 31: Oxcarbazepine added to the avoid list
  • 2011, June, 16; Paroxetine and Metoclopramide added to the preferably avoid list
  • 2011, January, 23; Tramadol added to the preferably avoid list
  • 2010, June, 13; Ketamine added to the preferably avoid list
  • 2010, February, 26; Diphenhydramine added to the preferably avoid list
  • 2009, December, 13; Dosulepine added to the preferably avoid list
  • 2009, November, 21; Fluvoxamine and Terfenadine/Fexofenadine added to the preferably avoid list
  • 2009, September; Official publication in Heart Rhythm
  • 2009, July, 10; Online publication on Heart Rhythm website
  • 2009, May; Website functional online

    Please take a moment to complete the user survey to support and improve this website

Please cite as:

    Postema, Wolpert, Amin et al. Heart Rhythm 2009;6(9):1335-1341 (PubMed / Full text)

Other language?